According to GenSight Biologics's latest financial reports the company's current revenue (TTM ) is $1.4 Million USD. In 2023 the company made a revenue of $1.4 Million USD a decrease over the revenue in the year 2022 that were of $2.76 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.